Literature DB >> 13268347

Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma.

P G FRICK.   

Abstract

Entities:  

Keywords:  FIBRIN; FIBRINOGEN; MYELOMA, PLASMA CELL/blood in

Mesh:

Substances:

Year:  1955        PMID: 13268347     DOI: 10.1093/ajcp/25.11.1263

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  7 in total

1.  Observations on the haemorrhagic diathesis in multiple myeloma.

Authors:  R HURLEY; S SHAW
Journal:  Postgrad Med J       Date:  1963-08       Impact factor: 2.401

2.  The biological significance of the anomalous serum and urinary proteins of myelomatosis, lymphoma, and other conditions.

Authors:  J A OWEN; C GOT
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

Review 3.  Re-evaluation of heat precipitation method for plasma fibrinogen estimation: effect of abnormal proteins and plasma viscosity.

Authors:  L Dintenfass; S Kammer
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

Review 4.  The immunoglobulins: a review.

Authors:  N H Martin
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

5.  A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin.

Authors:  H I Glueck; R Hong
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

6.  [On a simple technic for the quantitative determination of clot retraction and its application possibilities].

Authors:  G Niemeyer; W Schneider; R Gross
Journal:  Klin Wochenschr       Date:  1968-02-01

7.  Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.

Authors:  M J O'Kane; G B Wisdom; Z R Desai; G P Archbold
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.